Tech Company Financing Transactions
Distalmotion Funding Round
Revival Healthcare Capital and private investors invested in a $150 million Series G venture round for Distalmotion. The round was announced on 11/18/2025.
Transaction Overview
Company Name
Announced On
11/18/2025
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series G
Investors
Revival Healthcare Capital (Lead Investor) (Rick Anderson)
Proceeds Purpose
This new funding will be used primarily to accelerate US commercial adoption of DEXTER, its soft tissue robotic surgery system, as well as to support ongoing clinical and product development initiatives.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
Route de la Corniche 3 Bâtiment Phenyl
Epalinges, 1066
Switzerland
Epalinges, 1066
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Distalmotion stands for and invests in reliable engineering at the technological frontier -- technologies developed, engineered and manufactured by leading researchers, designers and assorted specialists in Switzerland. Dexter embodies the precision of robotic surgery and the reliability of Swiss engineering.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Friedrich
VP - Operations
Alexandre Berthoud
VP - R & D
Romain Farkas
VP - Sales
Matthias Reif
Browse more venture capital transactions:
Prev: 11/18/2025: Barker venture capital transaction
Next: 11/18/2025: Super7 venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs